GlaxoSmithKline Pharmaceuticals Limited at its Board of Directors meeting held on 7 February, 2022 have approved appointment of Mr. Juby Chandy and Cessation of Ms. Puja Thakur as Chief Financial Officer. The Board of Directors of the Company has appointed Mr. Juby Chandy as Chief Financial officer (CFO) of the company for period of three years from 1 April, 2022. He succeeds Ms. Puja Thakur who is moving to a senior finance role within GSK Group.

Mr. Chandy a Chartered Accountant is an experienced Finance Leader with a track record of achievement at regional and country level within Pharma /FMCG industries. Mr. Chandy joined GSK in 2007 and has held a number of leadership positions with increasing responsibilities across various geographies, including Finance Director for EM Central based in Turkey, Senior Finance Director for GSK Vietnam, Regional Finance Director for Emerging Markets, Area Finance Director for Emerging Market East & most recently, as Head of Finance for Global General Medicines, partnering with the leadership team on strategy, profit maximization, and delivering General Medicine performance.